Pfizer Recalls Lyrica Pregabalin Capsules for Deformed or Damaged Units
Pfizer is recalling specific lots of Lyrica (pregabalin) 75 mg capsules due to the potential presence of deformed or damaged capsules.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, and the hazard involves physical defects (deformed/damaged capsules) without reported injuries or deaths, fitting the criteria for a moderate severity recall.
Plain-English summary
Pfizer Inc. is recalling 116,400 bottles of Lyrica (pregabalin) 75 mg capsules, 90-count, prescription only. The recall is due to the potential presence of deformed or damaged capsules in specific lots.
The affected product is distributed by Parke-Davis, Division of Pfizer Inc. The recall covers lots M07862 (Exp 05/2018) and M07865 (Exp 06/2018). The product was distributed nationwide and in Puerto Rico.
Consumers with these specific lots should stop using the product and contact their healthcare provider or pharmacist for guidance on replacement or disposal.
The recalled product
- Product
- LYRICA (PREGABALIN)
- Brand
- LYRICA
- Manufacturer
- Pfizer Inc.
- Category
- Drug — Prescription Medication
- Hazard
- Affected units
- 116,400
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (4)
- Lot #: M07862
- Exp 05/2018
- M07865
- Exp 06/2018
UPCs (1)
- 0300711012683
Distribution
Part of a larger recall action
This product is one of 2 recalled by Pfizer Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 2 products in this recall →Related recalls
Same brand · LYRICA
- ModeratePfizer Recalls Lyrica Capsules Due to Deformed or Damaged Shells
FDA (Drugs) · 2016-02-10
Same manufacturer · Pfizer Inc.
See all →- HighSodium bicarbonate injection vials recalled for lack of assurance of sterility
FDA (Drugs) · 2025-08-27
- HighEpinephrine injection vials recalled for lack of assurance of sterility
FDA (Drugs) · 2025-08-27
- HighBicillin L-A 2.4 million unit vials recalled after particulates found
FDA (Drugs) · 2025-08-06
- HighBicillin L-A penicillin vials recalled after particulates found during visual inspection
FDA (Drugs) · 2025-08-06
- ModerateDobutamine Injection Recall Due to Discoloration and Cracked Vials
FDA (Drugs) · 2025-07-02
Same hazard · physical defect
See all →- HighThermodilution Catheter May Bend During Use, Causing Monitor Errors
FDA (Devices) · 2023-04-19
- ModerateBard Clean-Cath Intermittent Catheter Recalled for Packaging and Tip Defects
FDA (Devices) · 2021-04-28
- HighFerring Recalls ZOMA-Jet 5 Demonstration Kits Due to Defective Delivery System
FDA (Drugs) · 2021-04-07
- HighROi CPS Recalls Custom Procedure Packs with Flaking Gauze Sponges
FDA (Devices) · 2021-01-06
- HighGE Healthcare Recalls Flow Sensor Service Parts with Damaged Tubes
FDA (Devices) · 2020-11-11